Physician profile
Sarah Pack
NPI 1841853876
$3,924.80
in general payments reported to CMS, 2019-2025
9 companies · $3,719 in 2025
The $3,719 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.55 · 2023: $104 · 2024: $46.75 · 2025: $3,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947 · Travel and Lodging: $1,822 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.04 |
| Travel and Lodging | $1,822.22 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,971.91 | 2025 | Inspire |
| Harmony Biosciences LLC | $231.10 | 2024-2025 | |
| Lilly USA, LLC | $185.25 | 2025 | Zepbound, Mounjaro |
| Avadel Cns Pharmaceuticals, LLC | $158.81 | 2025 | Lumryz |
| Novo Nordisk INC | $124.21 | 2023-2024 | Wegovy |
| Jazz Pharmaceuticals INC. | $101.32 | 2025 | |
| Axsome Therapeutics, INC. | $63.22 | 2025 | Sunosi |
| Currax Pharmaceuticals LLC | $55.55 | 2021 | |
| Itamar Medical INC | $33.43 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Pack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.